High frequency of HPV16-associated head and neck squamous cell carcinoma in the Puerto Rican population

Head and Neck

Volumn 26, Issue 9, 2004, Pages 778-784

  Báez, Adriana ^a   Almodóvar, José I ^a   Cantor, Alan ^b   Celestin, Frederic ^a   Cruz Cruz, Luis ^a   Fonseca, Sharon ^a   Trinidad Pinedo, Juan ^a   Vega, William ^a  

^a UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Head and neck cancer; Hispanics; HPV16; Incidence; Survival

Indexed keywords

GENOMIC DNA; VIRUS DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER CELL CULTURE; CANCER INCIDENCE; CANCER SURVIVAL; CIGARETTE SMOKING; DNA SEQUENCE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NONHUMAN; OPEN READING FRAME; OROPHARYNX CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PUERTO RICO; SQUAMOUS CELL CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; FEMALE; HEAD AND NECK NEOPLASMS; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REPRESSOR PROTEINS;

EID: 4344670664     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20046     Document Type: Article

References (41)

1. Vokes EE, Weicheselbaum RR, Lipman SM, Hong WK. Head and neck cancer. N Eng J Med 1993;328:184-194.
2. Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC CancerBase No. 5. Lyon, IARC Press, 2001.
3. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988;48:3282-3287.
4. Saracci R. The interactions of tobacco smoking and other agents in cancer etiology. Epidemiol Rev 1987;9:175-193.
5. Ng SK, Kabat GC, Wynder EL. Oral cavity cancer in non-users of tobacco. J Natl Cancer Inst 1993;85:743-745.
6. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-265.
7. McKaig RG, Baric RS, Olshan AF. Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 1998;20:250-265.
8. Mao E-J, Schwartz SM, Daling JR, Oda D, Tickman L, Beckmann AM. Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia. Int J Cancer 1996;69:152-158.
9. ARC Working Group on the Evaluation of the Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 1995;64:277-282.
10. Scheffner M, Werness BA, Huibregtse JM, Levine JA, Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-1136.
11. Dyson N, Howley PM, Münger K, Harlow E. The human papillomavirus 16 E7 protein is able to bind the retinoblastoma gene product. Science 1989;243:934-937.
12. Havre PA, Yuan J, Hedrick L, Cho KR, Glazer PM. p53 inactivation by HPV E6 results in increased mutagenesis in human cells. Cancer Res 1995;55:4420-4424.
13. Kessis TD, Connolly DC, Hendrick L, Chen KR. Expression of HPV16 E6 or E7 increases integration of foreign DNA. Oncogene 1996;13:427-431.
14. Pirisi L, Yasumoto S, Feller M, Doniger J, DiPaolo JA. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 1987;61:1061-1066.
15. Liu X, Han S, Baluda MA, Park NH. HPV16 oncogenes E6 and E7 are mutagenic in normal human oral keratinocytes. Oncogene 1997;14:2347-2353.
16. Gillison MI, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709-720.
17. Nishioka S, Fukushima K, Nishizaki K, et al. Human papillomavirus as a risk factor for head and neck cancers - a case-control study. Acta Otolaryngol Suppl 1999;540:77-80.
18. Bouda M, Gorgoulis VG, Kastrinakis NG, et al. "High risk" HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa. Mod Pathol 2000;13:644-653.
19. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001;92:2875-2884.
20. Wiggins CL, Becker TM, Key CR, Samet JM. Cancer mortality among Hispanics, American Indians and non-Hispanic whites, 1958-1987. J Natl Cancer Inst 1993;85:1670-1678.
21. Day GL, Blot WJ, Austin DF, et al. Racial differences in risk of oral and pharyngeal cancer: alcohol, tobacco, and other determinants. J Natl Cancer Inst 1993;85:465-473.
22. Scully C, Bedi R. Ethnicity and oral cancer. Lancet Oncol 2000;1:37-42.
23. Haraf DJ, Nodzenski E, Brachman D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996;2:755-762.
24. Greenlee RT, Hill-Harmon MB, Murray T, Thun MI. Cancer statistics. CA Cancer J Clin 2001;51:15-36.
25. Puerto Rico Central Cancer Registry. Cancer in Puerto Rico. San Juan: Puerto Rico Department of Health; 2000.
26. Almodóvar J, Pérez SI, Arruza M, Morell CA, Báez A. Descriptive epidemiology of head and neck squamous carcinoma in Puerto Ricans. PR Health Sci 1996;15:251-255.
27. Snidjers PJ, Snijders PJ, Scholes AG, et al. Prevalence of mucosotropic human papillomaviruses in squamous-cell carcinoma of the head and neck. Int J Cancer 1996;66:464-469.
28. Paz IB, Cook N, Odom-Maryon T, Xie Y, Wilczynski SP. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997;79:595-604.
29. Scholes AG, Liloglou T, Snijders PJ, et al. p53 mutations in relation to human papillomavirus type 16 infection in squamous cell carcinomas of the head and neck. Int J Cancer 1997;71:796-799.
30. Clayman GL, Stewart MG, Weber RS, el-Naggar AK, Grimm EA. Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Arch Otolaryngol Head Neck Surg 1994;120:743-748.
31. Almadori G, Cadoni G, Cattani P, et al. Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res 2001;7:3988-3993.
32. Harty LC, Caporaso NE, Hayes RB, Shields PG. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J Natl Cancer Inst 1997;89:1698-1605.
33. Bosron WF, Li TK. Genetic polymorphism of human liver alcohol and aldehyde dehydrogenases and their relationship to alcohol metabolism and alcoholism. Hepatology 1986;6:502-510.
34. Coutelle C, Ward PJ, Fleury B, et al. Laryngeal and oropharyngeal cancer, alcohol dehydrogenase 3 and glutathione S-transferase M1 polymorphisms. Hum Genet 1997;99:319-325.
35. Sturgis EM, Castillo EJ, Li L, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;120:2125-2129.
36. Garrett LR, Perez-Reyes N, Smith PP, McDougall JK. Interaction of HPV-18 and nitrosomethylurea in the induction of squamous cell carcinoma. Carcinogenesis 1993;14:329-332.
37. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increase with progression of head and neck cancer. Cancer Res 1993;53:4477-4480.
38. Xi LF, Koutsky LA, Galloway DA, et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997;89:796-802.
39. Yamada T, Manos MM, Peto J, et al. Human pa pilloma virus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-2472.
40. Ellis JR, Keating PJ, Baird J, et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat Med 1995;1:464-470.
41. Zehbe I, Tachezy R, Mytilineos J, et al. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 2001:94:711-716.